Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1980 3
1981 2
1982 1
1983 4
1984 2
1985 5
1986 4
1987 6
1988 7
1989 13
1990 12
1991 6
1992 2
1993 3
1994 5
1995 3
1996 5
1997 3
1998 2
1999 4
2000 1
2001 1
2003 4
2004 3
2005 2
2006 2
2007 1
2008 2
2009 3
2010 2
2011 6
2012 3
2013 1
2014 2
2015 2
2016 6
2017 4
2018 4
2019 3
2020 6
2021 2
Text availability
Article attribute
Article type
Publication date

Search Results

148 results
Results by year
Filters applied: . Clear all
Page 1
Irinotecan, Temozolomide, and Dinutuximab With GM-CSF in Children With Refractory or Relapsed Neuroblastoma: A Report From the Children's Oncology Group.
Mody R, Yu AL, Naranjo A, Zhang FF, London WB, Shulkin BL, Parisi MT, Servaes SE, Diccianni MB, Hank JA, Felder M, Birstler J, Sondel PM, Asgharzadeh S, Glade-Bender J, Katzenstein H, Maris JM, Park JR, Bagatell R. Mody R, et al. Among authors: hank ja. J Clin Oncol. 2020 Jul 1;38(19):2160-2169. doi: 10.1200/JCO.20.00203. Epub 2020 Apr 28. J Clin Oncol. 2020. PMID: 32343642 Clinical Trial.
Combined innate and adaptive immunotherapy overcomes resistance of immunologically cold syngeneic murine neuroblastoma to checkpoint inhibition.
Voeller J, Erbe AK, Slowinski J, Rasmussen K, Carlson PM, Hoefges A, VandenHeuvel S, Stuckwisch A, Wang X, Gillies SD, Patel RB, Farrel A, Rokita JL, Maris J, Hank JA, Morris ZS, Rakhmilevich AL, Sondel PM. Voeller J, et al. Among authors: hank ja. J Immunother Cancer. 2019 Dec 6;7(1):344. doi: 10.1186/s40425-019-0823-6. J Immunother Cancer. 2019. PMID: 31810498 Free PMC article.
A Pilot Trial of Humanized Anti-GD2 Monoclonal Antibody (hu14.18K322A) with Chemotherapy and Natural Killer Cells in Children with Recurrent/Refractory Neuroblastoma.
Federico SM, McCarville MB, Shulkin BL, Sondel PM, Hank JA, Hutson P, Meagher M, Shafer A, Ng CY, Leung W, Janssen WE, Wu J, Mao S, Brennan RC, Santana VM, Pappo AS, Furman WL. Federico SM, et al. Among authors: hank ja. Clin Cancer Res. 2017 Nov 1;23(21):6441-6449. doi: 10.1158/1078-0432.CCR-17-0379. Epub 2017 Sep 22. Clin Cancer Res. 2017. PMID: 28939747 Free article. Clinical Trial.
In situ Vaccine Plus Checkpoint Blockade Induces Memory Humoral Response.
Baniel CC, Heinze CM, Hoefges A, Sumiec EG, Hank JA, Carlson PM, Jin WJ, Patel RB, Sriramaneni RN, Gillies SD, Erbe AK, Schwarz CN, Pieper AA, Rakhmilevich AL, Sondel PM, Morris ZS. Baniel CC, et al. Among authors: hank ja. Front Immunol. 2020 Jul 24;11:1610. doi: 10.3389/fimmu.2020.01610. eCollection 2020. Front Immunol. 2020. PMID: 32849544 Free PMC article.
NK cell-based immunotherapies in Pediatric Oncology.
McDowell KA, Hank JA, DeSantes KB, Capitini CM, Otto M, Sondel PM. McDowell KA, et al. Among authors: hank ja. J Pediatr Hematol Oncol. 2015 Mar;37(2):79-93. doi: 10.1097/MPH.0000000000000303. J Pediatr Hematol Oncol. 2015. PMID: 25590232 Free PMC article. Review.
Outcome-Related Signatures Identified by Whole Transcriptome Sequencing of Resectable Stage III/IV Melanoma Evaluated after Starting Hu14.18-IL2.
Yang RK, Kuznetsov IB, Ranheim EA, Wei JS, Sindiri S, Gryder BE, Gangalapudi V, Song YK, Patel V, Hank JA, Zuleger C, Erbe AK, Morris ZS, Quale R, Kim K, Albertini MR, Khan J, Sondel PM. Yang RK, et al. Among authors: hank ja. Clin Cancer Res. 2020 Jul 1;26(13):3296-3306. doi: 10.1158/1078-0432.CCR-19-3294. Epub 2020 Mar 9. Clin Cancer Res. 2020. PMID: 32152202 Free PMC article.
Antitumor Activity and Tolerability of hu14.18-IL2 with GMCSF and Isotretinoin in Recurrent or Refractory Neuroblastoma: A Children's Oncology Group Phase II Study.
Shusterman S, Naranjo A, Van Ryn C, Hank JA, Parisi MT, Shulkin BL, Servaes S, London WB, Shimada H, Gan J, Gillies SD, Maris JM, Park JR, Sondel PM. Shusterman S, et al. Among authors: hank ja. Clin Cancer Res. 2019 Oct 15;25(20):6044-6051. doi: 10.1158/1078-0432.CCR-19-0798. Epub 2019 Jul 29. Clin Cancer Res. 2019. PMID: 31358541 Free PMC article. Clinical Trial.
148 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page